Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

CAPRICOR THERAPEUTICS, INC. (CAPR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Capricor Therapeutics, Inc. Investors of Upcoming Deadline

$CAPRPress releaseSep 22, 2026, 10:48 AM ETRead the release

Bernstein Liebhard LLP issued a reminder that a securities fraud class action is pending against Capricor Therapeutics, with a lead-plaintiff deadline of September 28, 2026. The class period covers investors who purchased CAPR shares between December 17, 2025 and July 6, 2026; allegations cite materially false statements regarding business operations, growth prospects, and financial stability.

Key figures

Class period end
July 6, 2026
Class period start
December 17, 2025
Lead plaintiff deadline
September 28, 2026

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.